| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Veterinary Clinic, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan;
Department of Pathology, Toxicology Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan; Departments of
Immunology and
§
Dermatology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan; and
¶
Department of Veterinary Internal Medicine, Faculty of Agriculture, Tottori University, Tottori, Japan
IgE hyperproduction frequently observed in patients with atopic dermatitis (AD) may greatly contribute to the pathogenesis of AD, but its mechanisms are still unclear. NC/Nga mice raised in nonsterile circumstances spontaneously suffered from AD-like skin lesions with elevation of plasma IgE levels. We investigated mechanisms of the IgE hyperproduction in NC/Nga mice. Splenic T cells from SPF NC/Nga mice had a level of CD40 ligand (CD40L) expression comparable to that of BALB/c mice. Although there was no difference in the expression of CD40 on B cells between NC/Nga and BALB/c mice, B cells of NC/Nga mice produced much more IgE in the presence of soluble CD40L and IL-4. The stimulation with CD40L and/or IL-4 resulted in tyrosine phosphorylation of Janus kinase 3 (JAK3) in B cells, which was more strongly inducible in NC/Nga mice than in BALB/c mice. In B cells isolated from PBMC of AD patients with high serum IgE levels, JAK3 was constitutively phosphorylated at the tyrosine residue, and its phosphorylation was enhanced by the treatment with CD40L and/or IL-4 as was that in splenic B cells of NC/Nga mice with dermatitis and high IgE levels. Thus, it is suggested that constitutive and enhanced JAK3 phosphorylation in B cells highly sensitive to CD40L and IL-4 may be attributable to IgE hyperproduction in NC/Nga mice and patients with AD.
This article has been cited by other articles:
|
|
 |
|
  H. Fujimaki, K. Nohara, T. Kobayashi, K. Suzuki, K. Eguchi-Kasai, S. Tsukumo, M. Kijima, and C. Tohyama Effect of a Single Oral Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Immune Function in Male NC/Nga Mice Toxicol. Sci., March 1, 2002; 66(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Yagi, H. Nagai, Y. Iigo, T. Akimoto, T. Arai, and M. Kubo Development of Atopic Dermatitis-Like Skin Lesions in STAT6-Deficient NC/Nga Mice J. Immunol., February 15, 2002; 168(4): 2020 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Stepkowski, R. A. Erwin-Cohen, F. Behbod, M.-E. Wang, X. Qu, N. Tejpal, Z. S. Nagy, B. D. Kahan, and R. A. Kirken Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin Blood, January 15, 2002; 99(2): 680 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Fan, K. Kouda, H. Nakamura, and H. Takeuchi Effects of Dietary Restriction on Spontaneous Dermatitis in NC/Nga Mice Experimental Biology and Medicine, December 1, 2001; 226(11): 1045 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matsumoto, A. Itakura, A. Tanaka, C. Fujisawa, and H. Matsuda Inability of IL-12 to Down-Regulate IgE Synthesis Due to Defective Production of IFN-{gamma} in Atopic NC/Nga Mice J. Immunol., November 15, 2001; 167(10): 5955 - 5962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Habu, S. Seki, E. Takayama, T. Ohkawa, Y. Koike, K. Ami, T. Majima, and H. Hiraide The Mechanism of a Defective IFN-{{gamma}} Response to Bacterial Toxins in an Atopic Dermatitis Model, NC/Nga Mice, and the Therapeutic Effect of IFN-{{gamma}}, IL-12, or IL-18 on Dermatitis J. Immunol., May 1, 2001; 166(9): 5439 - 5447. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
